Discover powerful yet simple daily habits that can significantly enhance your diabetes management. From eating your veggies first to mindful breathing techniques, these expert tips will help you maintain better blood sugar levels and overall health.
A groundbreaking study reveals that combining the Mediterranean diet with calorie reduction and exercise can reduce the risk of Type 2 diabetes by 31%. Learn how these lifestyle changes can transform your health!
A groundbreaking study reveals that adopting a Mediterranean diet, reducing calories, and engaging in moderate exercise can lower type 2 diabetes risk by 31%. Discover how simple lifestyle changes can save millions from this global epidemic.
In a candid discussion, celebrities share their experiences with Ozempic and other weight loss medications, revealing surprising truths, struggles, and the societal pressures surrounding body image.
In a day marked by significant market movements, EchoStar's stock skyrocketed following AT&T's $23 billion purchase of wireless licenses. Eli Lilly also saw gains with promising diabetes drug results, while Nvidia's upcoming report looms large.
Lilly's new oral pill, Orforglipron, has shown promising results in reducing weight and improving blood sugar levels in diabetes patients. With nearly 4% rise in shares, the drug is on track for FDA approval.
Eli Lilly's new obesity pill, orforglipron, faces tough competition but could disrupt the weight loss market. Despite underwhelming trial results, analysts see potential for success due to manufacturing advantages and pricing strategies.
The AHA and ACC have released groundbreaking guidelines for managing high blood pressure in adults. Discover how personalized prevention and early treatment can empower you to take control of your health and reduce risks of heart disease, diabetes, and more!
New research reveals that 7,000 steps a day may be the optimal target for health benefits, contradicting the old 10,000-step goal. Discover how this number can reduce risks of diseases and enhance well-being.
Eli Lilly announces a dramatic price increase for its diabetes medication Mounjaro in the UK, raising the monthly cost from £122 to £330. This change affects private buyers but not NHS prescriptions. Learn more about the implications!
